A detailed history of Sectoral Asset Management Inc transactions in Bei Gene, Ltd. stock. As of the latest transaction made, Sectoral Asset Management Inc holds 2,637 shares of BGNE stock, worth $487,080. This represents 0.49% of its overall portfolio holdings.

Number of Shares
2,637
Previous 2,447 7.76%
Holding current value
$487,080
Previous $349,000 69.63%
% of portfolio
0.49%
Previous 0.17%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$143.93 - $224.51 $27,346 - $42,656
190 Added 7.76%
2,637 $592,000
Q2 2024

Aug 13, 2024

SELL
$129.52 - $174.32 $161,252 - $217,028
-1,245 Reduced 33.72%
2,447 $349,000
Q1 2024

May 14, 2024

SELL
$141.8 - $181.47 $8,508 - $10,888
-60 Reduced 1.6%
3,692 $577,000
Q4 2023

Feb 14, 2024

BUY
$158.67 - $201.58 $66,641 - $84,663
420 Added 12.61%
3,752 $676,000
Q3 2023

Nov 14, 2023

SELL
$179.87 - $225.13 $443,919 - $555,620
-2,468 Reduced 42.55%
3,332 $599,000
Q2 2023

Aug 11, 2023

BUY
$178.3 - $266.78 $51,707 - $77,366
290 Added 5.26%
5,800 $1.03 Million
Q1 2023

May 12, 2023

SELL
$215.53 - $274.5 $101,299 - $129,015
-470 Reduced 7.86%
5,510 $1.19 Million
Q4 2022

Feb 10, 2023

BUY
$125.51 - $229.3 $25,102 - $45,860
200 Added 3.46%
5,980 $1.32 Million
Q3 2022

Nov 10, 2022

BUY
$131.8 - $202.24 $92,260 - $141,568
700 Added 13.78%
5,780 $779,000
Q2 2022

Aug 15, 2022

BUY
$121.11 - $216.05 $60,555 - $108,025
500 Added 10.92%
5,080 $822,000
Q1 2022

May 10, 2022

SELL
$146.52 - $269.56 $29,304 - $53,912
-200 Reduced 4.18%
4,580 $864,000
Q4 2021

Feb 11, 2022

SELL
$248.56 - $389.34 $303,243 - $474,994
-1,220 Reduced 20.33%
4,780 $1.3 Million
Q2 2021

Aug 16, 2021

BUY
$292.75 - $367.01 $58,550 - $73,402
200 Added 3.45%
6,000 $2.06 Million
Q1 2021

May 14, 2021

BUY
$260.64 - $382.12 $1.51 Million - $2.22 Million
5,800 New
5,800 $2.02 Million
Q3 2019

Nov 14, 2019

SELL
$120.61 - $148.29 $1.35 Million - $1.66 Million
-11,227 Closed
0 $0
Q2 2019

Aug 14, 2019

BUY
$113.99 - $146.86 $34,197 - $44,058
300 Added 2.75%
11,227 $1.39 Million
Q1 2019

May 14, 2019

SELL
$122.82 - $151.83 $491,280 - $607,320
-4,000 Reduced 26.8%
10,927 $1.44 Million
Q4 2018

Feb 12, 2019

BUY
$107.01 - $175.15 $535,050 - $875,750
5,000 Added 50.37%
14,927 $2.09 Million
Q3 2018

Nov 14, 2018

BUY
$152.62 - $189.66 $1.52 Million - $1.88 Million
9,927 New
9,927 $1.71 Million

Others Institutions Holding BGNE

About BeiGene, Ltd.


  • Ticker BGNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,700,000
  • Market Cap $19.2B
  • Description
  • BeiGene, Ltd., a biotechnology company, focuses on discovering, developing, manufacturing, and commercializing various medicines worldwide. Its products include BRUKINSA to treat relapsed/refractory (R/R) mantle cell lymphoma; Tislelizumab to treat R/R classical Hodgkin's lymphoma; REVLIMID to treat multiple myeloma; VIDAZA to treat myelodysplas...
More about BGNE
Track This Portfolio

Track Sectoral Asset Management Inc Portfolio

Follow Sectoral Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sectoral Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Sectoral Asset Management Inc with notifications on news.